Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2019-04-24 13:50 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
59 - Exercise for cash
|
$-275,250
-11,010 vol $25.00 each |
0 | |
Filed 2019-04-24 13:48 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Options
59 - Exercise for cash
|
-102,683 vol |
0 | |
Filed 2019-04-24 13:47 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Holder: Gren Trust (Control or Direction)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-1,597,375
-63,895 vol $25.00 each |
0 | |
Filed 2019-04-22 11:11 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Tomasello, Shawn Cline
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
59 - Exercise for cash
|
$-239,775
-9,591 vol $25.00 each |
0 | |
Filed 2019-04-22 11:11 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Tomasello, Shawn Cline
4 - Director of Issuer
Direct Ownership
|
Options
59 - Exercise for cash
|
-35,970 vol |
0 | |
Filed 2019-04-22 11:06 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Shih, Fei
5 - Senior Officer of Issuer
Direct Ownership
|
Options
59 - Exercise for cash
|
-84,950 vol |
0 | |
Filed 2019-04-22 11:03 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Roy Grogan, Donna
5 - Senior Officer of Issuer
Direct Ownership
|
Options
59 - Exercise for cash
|
-499,394 vol |
0 | |
Filed 2019-04-22 11:02 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Roy Grogan, Donna
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-1,746,650
-69,866 vol $25.00 each |
0 | |
Filed 2019-04-22 10:55 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Packman, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Options
59 - Exercise for cash
|
-353,379 vol |
0 | |
Filed 2019-04-22 10:54 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Packman, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-2,617,125
-104,685 vol $25.00 each |
0 | |
Filed 2019-04-22 10:51 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
59 - Exercise for cash
|
$-280,200
-11,208 vol $25.00 each |
0 | |
Filed 2019-04-22 10:50 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Options
59 - Exercise for cash
|
-102,683 vol |
0 | |
Filed 2019-04-22 10:49 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-2,583,225
-103,329 vol $25.00 each |
0 | |
Filed 2019-04-22 10:45 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
59 - Exercise for cash
|
$-298,375
-11,935 vol $25.00 each |
0 | |
Filed 2019-04-22 10:44 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Options
59 - Exercise for cash
|
-142,681 vol |
0 | |
Filed 2019-04-22 10:43 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-1,468,775
-58,751 vol $25.00 each |
0 | |
Filed 2019-04-22 10:40 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
59 - Exercise for cash
|
$-280,800
-11,232 vol $25.00 each |
0 | |
Filed 2019-04-22 10:39 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Options
59 - Exercise for cash
|
-35,970 vol |
0 | |
Filed 2019-04-22 10:35 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Walewicz, Joseph Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
59 - Exercise for cash
|
-191,720 vol |
0 | |
Filed 2019-04-22 10:29 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Grinstead, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Options
59 - Exercise for cash
|
-434,760 vol |
0 | |
Filed 2019-04-22 10:19 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
59 - Exercise for cash
|
-389,100 vol |
0 | |
Filed 2019-04-22 10:15 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
59 - Exercise for cash
|
-1,657,757 vol |
0 | |
Filed 2019-04-22 10:14 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 3669661 Canada Inc. (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-20,351,350
-814,054 vol $25.00 each |
0 | |
Filed 2019-04-22 10:06 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
59 - Exercise for cash
|
$-145,425
-5,817 vol $25.00 each |
0 | |
Filed 2019-04-22 10:06 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
59 - Exercise for cash
|
-47,960 vol |
0 | |
Filed 2019-04-10 12:20 Tx date 2019-04-09 |
$CMTA
Clementia Pharmaceuticals Inc. |
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 3669661 Canada Inc. (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+814,054 vol |
814,054 | |
Filed 2019-04-10 12:20 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 3669661 Canada Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-04-10 12:19 Tx date 2019-04-09 |
$CMTA
Clementia Pharmaceuticals Inc. |
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-814,054 vol |
0 | |
Filed 2019-03-01 Tx date 2019-02-24 |
$CMTA
Clementia Pharmaceuticals Inc. |
Tomasello, Shawn Cline
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+7,845 vol |
9,591 | |
Filed 2019-03-01 Tx date 2019-02-24 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+7,845 vol |
11,232 | |
Filed 2019-03-01 Tx date 2019-02-24 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+7,845 vol |
11,935 | |
Filed 2019-03-01 Tx date 2019-02-24 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+7,845 vol |
11,208 | |
Filed 2019-03-01 Tx date 2019-02-24 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+7,845 vol |
11,010 | |
Filed 2019-02-21 Tx date 2019-02-18 |
$CMTA
Clementia Pharmaceuticals Inc. |
Packman, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+104,500 vol |
353,379 | |
Filed 2019-02-21 Tx date 2019-02-18 |
$CMTA
Clementia Pharmaceuticals Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+164,100 vol |
389,100 | |
Filed 2019-02-21 Tx date 2019-02-18 |
$CMTA
Clementia Pharmaceuticals Inc. |
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+463,300 vol |
1,657,757 | |
Filed 2019-02-21 Tx date 2019-02-18 |
$CMTA
Clementia Pharmaceuticals Inc. |
Roy Grogan, Donna
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+104,500 vol |
499,394 | |
Filed 2019-02-21 Tx date 2019-02-18 |
$CMTA
Clementia Pharmaceuticals Inc. |
Walewicz, Joseph Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+27,800 vol |
191,720 | |
Filed 2019-02-18 Tx date 2019-02-15 |
$CMTA
Clementia Pharmaceuticals Inc. |
BDC
3 - 10% Security Holder of Issuer
Holder: BDC Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,652,287.2144
-113,072 vol $14.61 each |
5,338,069 | |
Filed 2019-02-14 Tx date 2019-02-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
BDC
3 - 10% Security Holder of Issuer
Holder: BDC Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-121,088.048
-8,560 vol $14.15 each |
5,451,141 | |
Filed 2019-02-13 Tx date 2019-02-13 |
$CMTA
Clementia Pharmaceuticals Inc. |
BDC
3 - 10% Security Holder of Issuer
Holder: BDC Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-100,714.796
-7,105 vol $14.18 each |
5,459,701 | |
Filed 2019-02-12 Tx date 2019-02-12 |
$CMTA
Clementia Pharmaceuticals Inc. |
BDC
3 - 10% Security Holder of Issuer
Holder: BDC Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-285,925.0625
-20,405 vol $14.01 each |
5,466,806 | |
Filed 2019-02-11 Tx date 2019-02-11 |
$CMTA
Clementia Pharmaceuticals Inc. |
BDC
3 - 10% Security Holder of Issuer
Holder: BDC Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-82,736.88
-5,900 vol $14.02 each |
5,487,211 | |
Filed 2019-02-06 Tx date 2019-02-05 |
$CMTA
Clementia Pharmaceuticals Inc. |
BDC
3 - 10% Security Holder of Issuer
Holder: BDC Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,422.98
-600 vol $14.04 each |
5,493,111 | |
Filed 2019-02-04 Tx date 2019-02-04 |
$CMTA
Clementia Pharmaceuticals Inc. |
BDC
3 - 10% Security Holder of Issuer
Holder: BDC Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-35,587
-2,500 vol $14.23 each |
5,493,711 | |
Filed 2019-01-18 Tx date 2019-01-18 |
$CMTA
Clementia Pharmaceuticals Inc. |
BDC
3 - 10% Security Holder of Issuer
Holder: BDC Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,427
-100 vol $14.27 each |
5,496,211 | |
Filed 2019-01-16 Tx date 2019-01-16 |
$CMTA
Clementia Pharmaceuticals Inc. |
BDC
3 - 10% Security Holder of Issuer
Holder: BDC Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,800
-200 vol $14.00 each |
5,496,311 | |
Filed 2019-01-15 Tx date 2019-01-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
BDC
3 - 10% Security Holder of Issuer
Holder: BDC Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,846.97
-700 vol $14.07 each |
5,496,511 | |
Filed 2019-01-14 Tx date 2019-01-11 |
$CMTA
Clementia Pharmaceuticals Inc. |
BDC
3 - 10% Security Holder of Issuer
Holder: BDC Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,582.6496
-396 vol $14.10 each |
5,497,211 | |
Filed 2019-01-04 Tx date 2018-12-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+850 vol |
3,165 | |
Filed 2019-01-04 Tx date 2018-12-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+1,062 vol |
4,090 | |
Filed 2019-01-04 Tx date 2018-12-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+1,142 vol |
3,387 | |
Filed 2019-01-04 Tx date 2018-12-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+1,514 vol |
5,817 | |
Filed 2019-01-04 Tx date 2018-12-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Tomasello, Shawn Cline
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+850 vol |
1,746 | |
Filed 2019-01-04 Tx date 2018-12-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+903 vol |
3,363 | |
Filed 2018-11-29 Tx date 2018-11-06 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Options
56 - Grant of rights
|
+11,990 vol |
||
Filed 2018-11-29 Tx date 2018-11-06 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+11,990 vol |
47,960 | |
Filed 2018-11-29 Tx date 2018-11-06 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+11,990 vol |
142,681 | |
Filed 2018-11-29 Tx date 2018-11-06 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+11,990 vol |
||
Filed 2018-11-29 Tx date 2018-11-06 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+11,990 vol |
35,970 | |
Filed 2018-11-29 Tx date 2018-11-06 |
$CMTA
Clementia Pharmaceuticals Inc. |
Tomasello, Shawn Cline
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+11,990 vol |
35,970 | |
Filed 2018-11-29 Tx date 2018-11-06 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+11,990 vol |
102,683 | |
Filed 2018-11-29 Tx date 2018-11-06 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+11,990 vol |
102,683 | |
Filed 2018-10-04 Tx date 2018-09-30 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+1,597 vol |
4,303 | |
Filed 2018-10-04 Tx date 2018-09-30 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+1,121 vol |
3,028 | |
Filed 2018-10-04 Tx date 2018-09-30 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+1,205 vol |
2,245 | |
Filed 2018-10-04 Tx date 2018-09-30 |
$CMTA
Clementia Pharmaceuticals Inc. |
Tomasello, Shawn Cline
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+896 vol |
896 | |
Filed 2018-10-04 Tx date 2018-09-30 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+896 vol |
2,315 | |
Filed 2018-10-04 Tx date 2018-09-30 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+952 vol |
2,460 | |
Filed 2018-10-04 Tx date 2018-07-05 |
$CMTA
Clementia Pharmaceuticals Inc. |
Tomasello, Shawn Cline
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-07-16 Tx date 2018-07-12 |
$CMTA
Clementia Pharmaceuticals Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+225,000 vol |
225,000 | |
Filed 2018-07-16 Tx date 2018-07-12 |
$CMTA
Clementia Pharmaceuticals Inc. |
Forte, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-07-05 Tx date 2018-07-05 |
$CMTA
Clementia Pharmaceuticals Inc. |
Tomasello, Shawn Cline
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$294,474
+23,980 vol $12.28 each |
23,980 | |
Filed 2018-07-05 Tx date 2018-07-05 |
$CMTA
Clementia Pharmaceuticals Inc. |
Tomasello, Shawn Cline
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-07-04 Tx date 2018-06-30 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+1,021 vol |
1,907 | |
Filed 2018-07-04 Tx date 2018-06-30 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+1,448 vol |
2,706 | |
Filed 2018-07-04 Tx date 2018-06-30 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+759 vol |
1,419 | |
Filed 2018-07-04 Tx date 2018-06-30 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+807 vol |
1,040 | |
Filed 2018-07-04 Tx date 2018-06-30 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+807 vol |
1,508 | |
Filed 2018-04-20 Tx date 2018-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Packman, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
248,879 | |
Filed 2018-04-20 Tx date 2018-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Grinstead, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
434,760 | |
Filed 2018-04-20 Tx date 2018-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Walewicz, Joseph Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
163,920 | |
Filed 2018-04-20 Tx date 2018-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Singer, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
362,390 | |
Filed 2018-04-20 Tx date 2018-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Shih, Fei
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+5,000 vol |
84,950 | |
Filed 2018-04-20 Tx date 2018-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Roy Grogan, Donna
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
394,894 | |
Filed 2018-04-20 Tx date 2018-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
1,194,457 | |
Filed 2018-04-17 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-17 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+701 vol |
||
Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+701 vol |
||
Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+701 vol |
701 | |
Filed 2018-04-17 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-17 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-17 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+886 vol |
||
Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+886 vol |
||
Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+886 vol |
886 | |
Filed 2018-04-17 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+1,258 vol |
||
Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+1,258 vol |
1,258 | |
Filed 2018-04-17 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-17 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-17 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+660 vol |
||
Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+660 vol |
||
Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+660 vol |
660 | |
Filed 2018-04-17 Tx date 2018-01-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-17 Tx date 2018-01-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-17 Tx date 2018-01-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+233 vol |
||
Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+233 vol |
||
Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+233 vol |
233 | |
Filed 2018-04-17 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-17 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-17 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+1,258 vol |
||
Filed 2018-04-16 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+701 vol |
701 | |
Filed 2018-04-16 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+233 vol |
233 | |
Filed 2018-04-16 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-16 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+886 vol |
886 | |
Filed 2018-04-16 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-16 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-16 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+1,258 vol |
1,258 | |
Filed 2018-04-16 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-16 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+660 vol |
660 | |
Filed 2018-04-16 Tx date 2018-01-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-03-05 Tx date 2018-02-27 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$330,924
+23,980 vol $13.80 each |
23,980 | |
Filed 2018-03-05 Tx date 2018-02-27 |
$CMTA
Clementia Pharmaceuticals Inc. |
Walewicz, Joseph Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
95,920 | ||
Filed 2018-03-05 Tx date 2018-02-27 |
$CMTA
Clementia Pharmaceuticals Inc. |
Walewicz, Joseph Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+58,000 vol |
153,920 | |
Filed 2018-03-05 Tx date 2018-02-27 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$330,924
+23,980 vol $13.80 each |
||
Filed 2018-03-02 Tx date 2018-02-27 |
$CMTA
Clementia Pharmaceuticals Inc. |
Grinstead, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+60,000 vol |
424,760 | |
Filed 2018-03-02 Tx date 2018-02-27 |
$CMTA
Clementia Pharmaceuticals Inc. |
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+305,000 vol |
1,094,457 | |
Filed 2018-03-02 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Grinstead, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-03-02 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Grinstead, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-03-02 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Grinstead, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
364,760 | ||
Filed 2018-03-02 Tx date 2018-01-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-03-02 Tx date 2018-02-27 |
$CMTA
Clementia Pharmaceuticals Inc. |
Legault, Pierre
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$330,924
+23,980 vol $13.80 each |
23,980 | |
Filed 2018-03-02 Tx date 2018-02-27 |
$CMTA
Clementia Pharmaceuticals Inc. |
Packman, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
208,879 | |
Filed 2018-03-02 Tx date 2018-02-27 |
$CMTA
Clementia Pharmaceuticals Inc. |
Roy Grogan, Donna
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+60,000 vol |
354,894 | |
Filed 2018-03-02 Tx date 2018-02-27 |
$CMTA
Clementia Pharmaceuticals Inc. |
Shih, Fei
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
59,950 | ||
Filed 2018-03-02 Tx date 2018-02-27 |
$CMTA
Clementia Pharmaceuticals Inc. |
Shih, Fei
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
79,950 | |
Filed 2018-03-02 Tx date 2018-02-27 |
$CMTA
Clementia Pharmaceuticals Inc. |
Singer, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
342,390 | |
Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Roy Grogan, Donna
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
294,894 | ||
Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Roy Grogan, Donna
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
69,866 | ||
Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Packman, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
168,879 | ||
Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Packman, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Packman, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
104,685 | ||
Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Packman, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
130,691 | ||
Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
58,751 | ||
Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
90,693 | ||
Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Grinstead, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
366,211 | ||
Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Grinstead, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
35,970 | ||
Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Heft, Robert
4 - Director of Issuer
Holder: Gren Trust (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
63,895 | ||
Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Morrell Mott, David
4 - Director of Issuer
Holder: New Enterprise Associates 15, L.P. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,140,246 | ||
Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
103,329 | ||
Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
90,693 | ||
Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Morrell Mott, David
4 - Director of Issuer
Holder: New Enterprise Associates 15, L.P. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-08-22 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
789,457 | ||
Filed 2017-08-22 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
814,054 | ||
Filed 2017-08-22 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Bonita, David P.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
35,970 | ||
Filed 2017-08-22 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Grinstead, Eric
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
366,211 | ||
Filed 2017-08-22 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
103,329 | ||
Filed 2017-08-22 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Singer, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
252,390 | ||
Filed 2017-08-22 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Singer, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
26,378 | ||
Filed 2017-08-22 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Packman, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
168,879 | ||
Filed 2017-08-22 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Packman, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
104,685 | ||
Filed 2017-08-22 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Orbimed Advisors LLC
3 - 10% Security Holder of Issuer
Holder: OrbiMed Private Investments IV, LP (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
10,425,225 | ||
Filed 2017-08-22 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
90,693 | ||
Filed 2017-08-22 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Morrell Mott, David
4 - Director of Issuer
Holder: New Enterprise Associates 15, L.P. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,140,246 |